Bachem Granted Manufacturing License by Japanese Ministry of Health Labour and Welfare

Press Release – Bachem AG
Bachem Granted Manufacturing License by Japanese Ministry of Health, Labour and Welfare

Bachem Quality Logo

New Bachem Logo 176 x 50

Contact Supplier: Bachem AG
Supplier Press Release: Bachem Granted Manufacturing License by Japanese MHLW
Address: Hauptstrasse 144, 4416 Bubendorf, Switzerland
Tel: +41 61 935 2323
Fax: +41 61 935 2325

NOVEMBER 15, 2012

Bachem Granted Manufacturing License by Japanese Ministry of Health, Labour and Welfare

Bachem AG, the internationally recognized manufacturer of the highest quality biochemical and pharmaceutical drug products for the pharma and biotech industry has been granted a renewed manufacturing license in conformity by the Japanese Ministry of Health, Labour and Welfare (MHLW). The license allows Bachem to continue to manufacture active pharmaceutical ingredients intended for the Japanese market.

All three of Bachem’s GMP production facilities – Switzerland based, Bachem AG in Bubendorf and Bachem SA, Succursale de Vionnaz and US based Bachem Americas, Inc. in Torrance, California have met the strong requirements to achieve the license and supply the Japanese market for many years.

The license and Bachem’s extensive experience in the registration of master files in Japan allows the company to supply Japan based pharmaceutical and biotech companies with the required quantities of APIs ranging from small quantities for development projects to bulk deliveries for successfully marketed products.

About Bachem
Bachem is a listed technology-based company focused on peptide chemistry. The company provides a full range of services to the pharma and biotech industries.

It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients. A comprehensive catalog of biochemicals and exclusive custom syntheses for research labs complete the service portfolio.

Headquartered in Switzerland with subsidiaries in Europe and the US, the group has a global reach with more experience and know-how than any other company in the industry. Towards its customers, Bachem shows total commitment to quality, innovation and partnership.

Bachem. Pioneering Partner for Peptides

Press Contact:
Bachem Holding AG
Stephan Schindler
Chief Financial Officer
Tel: +41 61 935 23 33

For more information or to discuss Bachem granted manufacturing license by Japanese MHLW please contact us directly.

Comments are closed.